UPDATE 1-Ironwood appoints Sarissa's Denner to board; shares surge [Reuters]
Ironwood Pharmaceuticals, Inc. - Class A (IRWD)
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.ironwoodpharma.com
Company Research
Source: Reuters
By Svea Herbst-Bayliss 3 Min Read (Adds details about company, Sarissa’s involvement) BOSTON, Nov 6 (Reuters) - Ironwood Pharmaceuticals on Friday handed a board seat to Sarissa Capital Management, sparking its shares to surge as much as 14% when the activist investor secured the spot after a quiet but forceful 2-1/2-year campaign to join the group. Alexander Denner, a widely known healthcare investor who founded Sarissa in 2013, will join Ironwood’s board as its 10th director, the company said. “His wealth of knowledge will be invaluable as we continue on our mission to advance GI (gastrointestinal) medicines, redefine the standard of care for GI patients, and deliver shareholder value,” Julie McHugh, chair of Ironwood’s board, said in a statement about Denner. The company’s shares were trading at $10.94, up 9%, at midday. Ever since Sarissa, which owned 14 million shares, or roughly 9% of the Boston-based company, at the end of June, bought into Ironwood in late 2017, Denner has wa
Show less
Read more
Impact Snapshot
Event Time:
IRWD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRWD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRWD alerts
High impacting Ironwood Pharmaceuticals, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
IRWD
News
- ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire
- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire
- ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire
- INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire
IRWD
Earnings
- 2/15/24 - Miss
IRWD
Sec Filings
- 3/19/24 - Form 4
- 3/12/24 - Form 4
- 3/12/24 - Form 4
- IRWD's page on the SEC website